title: Ofloxacin, a new quinolone for the treatment of gonorrhea.
abstract: Forty-three patients with uncomplicated gonorrhea were treated with 400 mg of ofloxacin. All had cultures negative for Neisseria gonorrhoeae at follow-up within two weeks of treatment. Minimal side effects were reported. Ofloxacin appears to be satisfactory as a single-dose oral drug for the treatment of gonococcal urethritis, including those cases caused by penicillinase-producing strains of N. gonorrhoeae.
authors.affiliation: Department of Medical Microbiology, University Hospital, Kuala Lumpur, Malaysia.
authors.forename: M K
authors.initials: MK
authors.lastname: Rajakumar
authors.forename: Y F
authors.initials: YF
authors.lastname: Ngeow
authors.forename: B S
authors.initials: BS
authors.lastname: Khor
authors.forename: K F
authors.initials: KF
authors.lastname: Lim
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin; D010078:Oxazines / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D010078:Oxazines; D015242:Ofloxacin